法国心力衰竭的流行病学
Amélie Gabet1, Jacques Blacher2, Françoise Pousset3
1Santé Publique France, 94410 Saint-Maurice, France.
Archives of cardiovascular diseases
|November 15, 2024
概括
心力衰竭 (HF) 影响2.6%的法国成年人,贫困地区住院率更高. 改善心血管疾病预防和适应医疗保健对于管理这一公共卫生问题至关重要.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 由于人口老龄化,心力衰竭 (HF) 是欧洲日益严重的公共卫生问题.
- 了解HF流行病学对于有效的公共卫生战略至关重要.
研究的目的:
- 为法国提供2022年心力衰竭 (HF) 的最新流行病学概况.
- 分析HF患病率,住院率和患者的治疗结果.
主要方法:
- 利用法国国家健康数据系统 (SNDS) 来识别2022年因高温肺炎住院的成年人.
- 通过将住院数据与长期疾病记录相结合,估计HF患病率.
- 分析住院患者及其住院期间的社会人口统计和医疗数据.
主要成果:
- 在2022年,有181,178名成年人因HF住院,在成年人群中占2.6%的患病率.
- 社会经济贫困地区的住院率是社会经济贫困地区的1.6倍,区域差异很大.
- 住院死亡率为10.2%,一年死亡率达到34.0%.
结论:
- 由于法国各部门的高风险住院率存在显著差异,因此需要加强心血管预防措施.
- 调整医疗保健供应以应对社会经济因素和区域需求对于改善患者结果至关重要.
- 更加严格地遵守治疗指南,并考虑社会决定因素,可以改善患者短期的治疗结果.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5


